McKesson Corporation (MCK)
Here's Why McKesson (MCK) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
McKesson Q1 Earnings Call Highlights
McKesson NYSE: MCK reported fiscal first-quarter 2027 results that exceeded its expectations, citing broad-based momentum across its operating businesses and prompting the healthcare services company to raise its full-year adjusted earnings outlook.
McKesson (MCK) is an Incredible Growth Stock: 3 Reasons Why
McKesson (MCK) could produce exceptional returns because of its solid growth attributes.
MCK Stock Up as Q1 Earnings Beat on Specialty Growth, Guidance Raised
McKesson shares rise after fiscal Q1 earnings and revenues beat estimates, powered by specialty growth, as the company raises its 2027 EPS outlook.
MCK Q1 Earnings Call Centers on Pharma-Led Guidance Raise
McKesson raises fiscal 2027 earnings guidance after pharma profit rises 19%, while specialty demand, oncology growth and disciplined spending shape the call.
Why McKesson (MCK) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
McKesson Corporation (MCK) Q1 2027 Earnings Call Transcript
McKesson Corporation (MCK) Q1 2027 Earnings Call Transcript
McKesson (MCK) Q1 Earnings and Revenues Top Estimates
McKesson (MCK) came out with quarterly earnings of $9.93 per share, beating the Zacks Consensus Estimate of $9.44 per share. This compares to earnings of $8.26 per share a year ago.
McKesson (MCK) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for McKesson (MCK) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Healthcare Stocks Have Been Forgotten. Eli Lilly, McKesson, and 9 More to Buy.
A few sectors have dominated the market this year, and healthcare isn't one of them. Many stocks in the sector look ready to gain.
Why McKesson (MCK) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Can AI-Driven Efficiency and Specialty Demand Boost MCK's Q1 Results?
McKesson heads into Q1 with AI-driven efficiency, specialty momentum and oncology growth in focus as pricing dynamics may temper revenues.
